Home › Urologic Cancer › Massachusetts
Urologic Cancer clinical trials in Massachusetts
5 studies for Urologic Cancer are looking for participants at sites in Massachusetts.
Cities in Massachusetts
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Massachusetts General Hospital, Boston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06465069Urologic Lymphadenectomy in AMIGO
- Brigham and Women's Hospital, Boston
Recruiting
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT05132283uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
- Mass General Brigham, Boston
- Brigham and Women's Hospital, Boston
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT05874921FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- Massachusetts General Hospital, Boston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT05614739Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy
- Harvard School of Medicine/Massachusetts General Hospital (MGH), Boston
Recruiting
Ages 18 and older · All sexes · Updated Aug 14, 2025 · NCT04442724From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.